Skip to content
Lung Cancer Considered cover art

All episodes

Lung Cancer Considered, 421 episodes. Page 4 of 5.

#
Title
301

Finding Your First Job With Mark Awad Jyoti Patel And Ana Velazquez Manana

302

Mesothelioma With Melina Marmarelis And Sanjay Popat

303

Virtual Tumor Board PDL1 Negative NSCLC With Reyes Bernabé And Hoss Borghaei

304

Trastuzumab - Deruxtecan (T-DXd) With Lyudmila Bazhenova And Julien Mazieres

305

WCLC 2022 Wrap Up

306

WCLC 2022 Daily Highlights - August 9

307

WCLC 2022 Daily Highlights (Spanish Version) - August 8

308

WCLC 2022 Daily Highlights - August 8

309

WCLC 2022 Daily Highlights - August 7

310

WCLC 2022 Preview with Meeting Chairs Robert Pirker and Silvia Novello

311

IASLC Fellowship Grants With Grace Dy Fred Hirsch And Jarushka Naidoo

312

WCLC 2022 Preview With Narjust Florez And Stephen Liu

313

Women In Thoracic Oncology With Prunella Blinman And Clarissa Mathias

314

Lung Cancer in Germany with Alessandra Curioni Martin Reck and Juergen Wolfe

315

Lung Cancer In South Africa With Ronwyn Van Eeden

316

International Medical Graduates With Marina Chiara Garassino And Suresh Ramalingam

317

ASCO 2022 Highlights

318

Antibody Drug Conjugates (ADC) with Ben Levy And Rebecca Heist

319

Lung Cancer In India With Navneet Singh

320

Smoking Cessation And Stigma With Jamie Ostroff Matthew Steliga And Jim Pantelas

321

Lung Cancer Screening With Hilary Robbins And Brendon Stiles

322

Climate Change and Lung Cancer With Joan Schiller and Eric Bernicker

323

Lung Cancer Considered 100th Episode - Interview with new IASLC CEO, Dr. Karen Kelly

324

ELCC 2022 Highlights With Nicolas Girard And Lizza Hendriks

325

Breakthrough Therapies NTRK With Robert Doebele

326

Targeted Therapies of Lung Cancer with Charu Aggarwal Lecia Sequist and Ivy Elkins

327

NTRK with Herbert Ho Fung Loong

328

ALK-Fusion Positive NSCLC With Jessica Jiyeong Lin And Ben Solomon

329

Breakthrough Therapies EGFR Mutant Lung Cancer with Zosia Piotrowska

330

Cell Therapy With Ben Creelan And Prasad Adusumilli

331

Virtual Tumor Board EGFR With Helena Yu And Alfredo Addeo

332

Breakthrough Therapies - NRG1 with Dr. Laskin and Dr. Cadranel

333

LALCA 2021 Highlights With Luis E. Raez Christian Rolfo Lucia Viola

334

Virtual Tumor Board NSCLC - Anthony Kim And Patricia Rivera

335

IASLC Stars - Lillian Leigh, Erika Hlavacek, Caleb Egwuenu

336

Global Advocacy - Dr. Anne-Marie Baird

337

Lung Cancer in Korea - Chul Kim, Young Tae Kim and Sun Min Lim

338

Virtual Tumor Board NSCLC - Stephen Liu Erin Gillaspie And Shankar Siva

339

Lung Cancer Advocate and Pro Golfer - Jason Day

340

White Ribbon Project - Heidi Nafman-Onda, Dr. Pierre Onda and Chris Draft

341

SCLC Research - Charles Rudin and Tripnara Sen

342

Tumor Board Discussion: SCLC with Lauren Byers and Santiago Ponce Aix

343

ESMO Highlights - Solange Peters and Pasi Janne

344

Politics and Medicine/Cancer with Nasser Hanna and Raja Flores

345

Peer to Peer: Issues, Strategies and Impact with Dr. Nathan Pennell

346

2021 WCLC Highlights: Higgins, Harpole and Stinchcombe

347

Meet Our President and President Elect - Heather Wakelee and Paul Van Schil

348

Breakthrough Therapies - BRAF with Ibiayi Dagogo-Jack

349

Breakthrough Therapies- HER2 with Dr. Bob T. Li

350

Virtual Tumor Board: NSCLC/Metastatic KRAS G12V with Misako Nagasaka and Antonio Passaro

351

Career Paths with Dr. Tom John

352

Lung Cancer in Italy - In Italian: Dr. Marina Garissino and Dr. Silvia Novello

353

Financial Toxicity with Dr. Fumiko Chino

354

ASCO 2021 Highlights with Dr. Heather Wakelee and Dr. Alfredo Addeo

355

Neoadjuvant IO with Patrick Forde and Leah Backhus

356

FDA with Dr. Harpreet Singh

357

Virtual Tumor Board: NSCLC - Higgins and Calles

358

Seminal Trials Series - KEYNOTE 001 with Dr Edward Garon and Cary Parton: Patient Input

359

KRAS G12C Mutation with Dr. Tetsuya Mitsudomi

360

Tumor Board Discussion: Mesothelioma - Nowak and Mansfield

361

Breakthrough Therapies - ALK with Dr. Ignatius Ou

362

ELCC Highlights - Felip and Barlesi

363

Tumor Board Discussion- Paik and Felip

364

Developing the Moderna COVID-19 Vaccine

365

ROS1 Lung Cancer with Dr. Myung-Ju Ahn

366

RET Fusions in Lung Cancer with Dr. Alex Drilon

367

EGFR Resistance and Beyond with Dr. Balazs Halmos

368

WCLC 2020 Highlights and Wrap-Up

369

Tips and Tricks for Navigating IASLC WCLC

370

Women In Thoracic Oncology

371

Lung Cancer Considered Introduces New Podcast Hosts

372

Biological/Molecular Staging with Dr. Daniel Boffa

373

Practicing Medicine and Obtaining Treatments in Low & Middle-Income Countries

374

Continuing the Conversation: Overcoming Lung Cancer Stigma

375

Changing the Conversation: Overcoming Stigma Through Language and Action

376

Immunotherapy for Lung Cancer Patients with Dr. Matt Hellman

377

Throwback to WCLC 2019

378

Equity in Medicine

379

Digital Connections as an Educational Tool

380

IASLC Hot Topics on Liquid Biopsy

381

The IASLC Pathology Committee’s Creation of the IHC Atlas

382

Pros and Cons of Telemedicine

383

ADAURA: A Lively Debate Among Key Voices

384

Tumor Mutational Burden and COVID19 – A Pathologist’s Perspective

385

COVID-19 Impact on Conferences and Social Media with Dr. Tatiana Prowell from the FDA

386

Post AACR Debrief with Dr. Greg Riely

387

American Society of Clinical Oncology Virtual Meeting Highlights

388

IASLC Radiation Oncology and COVID-19 Webinar Recap

389

What Patients Need to Know About Lung Cancer Research in the Era of COVID-19

390

Around The World: COVID-19 and Lung Cancer Tips and Experiences

391

How To Find Information on COVID-19 In Different Regions- Spanish Language

392

COVID-19 Guidelines for Patients with Lung Cancer with Dr. Erin Bange

393

JTO Study on Smoking Cessation Impact with Dr. Rafael Meza

394

COVID-19 JTO Report with Dr. Shu-Yuan Xiao

395

COVID-19 Facts and Impacts for the Lung Cancer Community

396

Interview with IASLC President- Dr. Tetsuya Mitsudomi

397

Highlights from 20th IASLC 2020 Lung Cancer Targeted Therapies Conference

398

IASLC 2020 Lung Cancer Targeted Therapies Meeting

399

Interview with IASLC Chief Science Officer Dr. Chandra Belani

400

American Cancer Society Report with CSO Dr. Chandra Belani